Ciatto S, Visioli C, Paci E, Zappa M
Centro per lo Studio e la Prevenzione Oncologica, Viale Volta 171, 50131 Firenze, Italy.
Br J Cancer. 2004 Jan 26;90(2):393-6. doi: 10.1038/sj.bjc.6601548.
The association of breast density (% of breast volume involved by fibro-glandular densities) with the risk of interval cancer (IC) was investigated by reviewing a consecutive series of 346 cancers detected at screening (SDC) during 1996-1999 and of 90 ICs, reported as negative in the same period and diagnosed in the following 2 years, and comparing them to a random sample of 360 healthy controls. The probability of IC was significantly associated with breast density, whatever grouping (0/1-25/26-74/>74%; 0-25/26-60/61-74/>74%; 0-25/26-74/>74%) was considered (chi(2)=30.67-34.08, P<0.<0.01): 27.8% of all ICs were classified in the >74% density class, as compared to 7% of SDC and 5% of healthy controls. No significant association to IC was observed for Wolfe pattern (P2/Dy vs N1/P1: chi(2)=0.30, P=0.960), number of used mammographic views (single oblique vs oblique+craniocaudal: chi(2)=0.02, P=0.90) or screening round (first vs repeat: chi(2)=1.41, P=0.23). Multivariate analysis confirmed the independent association of breast density to IC, the highest risk being observed for >74% density class (OR vs 0% class=13.4, 95% CI 2.7-65.6, OR vs all other density classes=5.1, 95% CI 2.6-10.0). Age showed an independent association too, older women having a lower risk of IC (OR=0.52 95% CI 0.3-09). Breast density (>74%) resulted as being a major determinant of IC. Special screening protocols (shorter rescreening interval, routine use of ultrasonography) might be suggested for these subjects in order to improve screening sensitivity and efficacy.
通过回顾1996 - 1999年期间在筛查中发现的346例癌症(筛查发现癌症,SDC)以及90例间期癌(IC)(同期报告为阴性且在接下来两年中确诊),并将它们与360名健康对照的随机样本进行比较,研究了乳腺密度(纤维腺密度占乳腺体积的百分比)与间期癌风险之间的关联。无论采用何种分组方式(0/1 - 25/26 - 74/>74%;0 - 25/26 - 60/61 - 74/>74%;0 - 25/26 - 74/>74%),IC的发生概率都与乳腺密度显著相关(卡方值 = 30.67 - 34.08,P < 0.01):所有IC中有27.8%被归类为密度>74%组,而SDC组为7%,健康对照组为5%。未观察到沃尔夫模式(P2/Dy与N1/P1:卡方值 = 0.30,P = 0.960)、使用的乳腺钼靶投照体位数量(单斜位与斜位 + 头尾位:卡方值 = 0.02,P = 0.90)或筛查轮次(首次与重复:卡方值 = 1.41,P = 0.23)与IC有显著关联。多因素分析证实了乳腺密度与IC的独立关联,密度>74%组的风险最高(与0%组相比,比值比 = 13.4,95%置信区间2.7 - 65.6;与所有其他密度组相比,比值比 = 5.1,95%置信区间2.6 - 10.0)。年龄也显示出独立关联,年龄较大的女性患IC的风险较低(比值比 = 0.52,95%置信区间0.3 - 0.9)。乳腺密度(>74%)是IC的主要决定因素。对于这些受试者,可能建议采用特殊的筛查方案(缩短复查间隔、常规使用超声检查)以提高筛查的敏感性和有效性。